Carl P. Sherr & Co’s AbbVie ABBV Stock Holding History

Carl P. Sherr & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Hold	4,653	–	–	0.48%	47
2025 Q4	$1.04M	Hold	4,653	–	–	0.46%	44
2025 Q3	$1.08M	Buy	4,653 +50	+1%	+$10.2K	0.51%	43
2025 Q2	$854K	Sell	4,603 -250	-5%	-$46.5K	0.43%	47
2025 Q1	$1.02M	Hold	4,853	–	–	0.56%	42
2024 Q4	$862K	Hold	4,853	–	–	0.45%	48
2024 Q3	$958K	Hold	4,853	–	–	0.5%	45
2024 Q2	$832K	Sell	4,853 -417	-8%	-$69.1K	0.46%	50
2024 Q1	$960K	Hold	5,270	–	–	0.54%	47
2023 Q4	$817K	Sell	5,270 -200	-4%	-$29.2K	0.49%	52
2023 Q3	$815K	Hold	5,470	–	–	0.55%	51
2023 Q2	$737K	Hold	5,470	–	–	0.48%	53
2023 Q1	$872K	Hold	5,470	–	–	0.62%	39
2022 Q4	$884K	Sell	5,470 -4	-0.1%	-$613	0.67%	43
2022 Q3	$735K	Buy	5,474 +721	+15%	+$103K	0.59%	45
2022 Q2	$728K	Buy	4,753 +350	+8%	+$53.5K	0.54%	50
2022 Q1	$714K	Sell	4,403 -350	-7%	-$50.8K	0.48%	59
2021 Q4	$644K	Buy	4,753 +285	+6%	+$33.7K	0.39%	67
2021 Q3	$482K	Hold	4,468	–	–	0.38%	60
2021 Q2	$503K	Hold	4,468	–	–	0.35%	68
2021 Q1	$484K	Sell	4,468 -21	-0.5%	-$2.25K	0.36%	67
2020 Q4	$481K	Buy	4,489 +21	+0.5%	+$2.02K	0.38%	72
2020 Q3	$391K	Hold	4,468	–	–	0.35%	74
2020 Q2	$439K	Hold	4,468	–	–	0.44%	73
2020 Q1	$340K	Buy	4,468 +75	+2%	+$6.39K	0.4%	76
2019 Q4	$389K	Buy	+4,393	New	+$365K	0.38%	78

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carl P. Sherr & Co's ABBV Position: Q1 2026 in Review

Carl P. Sherr & Co held its AbbVie (ABBV) position steady in Q1 2026 at 4,653 shares worth $1.01M. The position accounts for 0.48% of the portfolio, ranked #47.

Carl P. Sherr & Co first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.08M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Carl P. Sherr & Co held 4,653 shares of AbbVie worth $1.01M as of Q1 2026.
Carl P. Sherr & Co left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.48% of Carl P. Sherr & Co's portfolio in Q1 2026, its #47 holding.
Carl P. Sherr & Co first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
Carl P. Sherr & Co's AbbVie position peaked at $1.08M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Carl P. Sherr & Co's 13F filing for Q1 2026, filed 7 May 2026.